Cat.#: ACPP-1724
| Despition | FGF13 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1374 | Human Ephrin A4 Protein (AC1374) | 2 µg | inquiry |
| ACPP-1280 | SRPX2 Blocking Peptide (AC1280) | 250 µg | inquiry |
| ACPP-1017 | Recombinant Human FGF19 Protein (AC1017) | 50 µg | inquiry |
| ACPP-1518 | Human MANF Protein, His (AC1518) | 5 µg | inquiry |
| ACPP-1596 | Human SPG21 Protein (AC1596) | 5 µg | inquiry |
| ACPP-1549 | Human VEGF C Protein (AC1549) | 2 µg | inquiry |
| ACPP-1272 | Bestrophin Blocking Peptide (AC1272) | 250 µg | inquiry |
| ACPP-1695 | Human LGALS9 Protein (AC1695) | 2 µg | inquiry |
| ACPP-1199 | Beta crystallin S Blocking Peptide (AC1199) | 250 µg | inquiry |
| ACPP-1223 | PAX8 Blocking Peptide (AC1223) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.